We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+40.55%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.47B
AUM Growth
+$207M
Cap. Flow
-$137M
Cap. Flow %
-9.32%
Top 10 Hldgs %
9.07%
Holding
898
New
262
Increased
152
Reduced
230
Closed
245

Top Buys

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$9.29M
2
ZEN
ZENDESK INC
ZEN
+$9.24M
3
NTAP icon
NetApp
NTAP
+$8.82M
4
BFAM icon
Bright Horizons
BFAM
+$8.68M
5
LLY icon
Eli Lilly
LLY
+$8.53M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$31.8M
2
HUM icon
Humana
HUM
+$24.8M
3
EOG icon
EOG Resources
EOG
+$17.3M
4
DINO icon
HF Sinclair
DINO
+$9.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Healthcare 23.44%
3 Consumer Discretionary 13.66%
4 Industrials 10.93%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RACE icon
1
Ferrari
RACE
$63.3B
$29.6M 2.01%
173,463
-41,255
-19% -$6.65M
CGNX icon
2
Cognex
CGNX
$10.3B
$15.8M 1.08%
264,900
-169,303
-39% -$9.19M
AVLR
3
DELISTED
Avalara, Inc.
AVLR
$14.9M 1.01%
111,801
-800
-0.7% -$78.6K
BE icon
4
Bloom Energy
BE
$52.6B
$14.2M 0.97%
1,307,851
+1,189,288
+1,003% +$9.29M
ZEN
5
DELISTED
ZENDESK INC
ZEN
$10.6M 0.72%
+119,997
New +$9.24M
BFAM icon
6
Bright Horizons
BFAM
$3.99B
$10.3M 0.7%
87,722
+76,001
+648% +$8.68M
CME icon
7
CME Group
CME
$92.2B
$9.75M 0.66%
60,000
WDAY icon
8
Workday
WDAY
$33.4B
$9.48M 0.65%
50,600
-5,932
-10% -$959K
ESTC icon
9
Elastic
ESTC
$6.1B
$9.33M 0.64%
101,211
+88,382
+689% +$6.46M
AAPL icon
10
Apple
AAPL
$4.89T
$9.31M 0.63%
102,084
-39,692
-28% -$3.08M
RMD icon
11
ResMed
RMD
$28.3B
$9.18M 0.62%
47,809
-16,209
-25% -$2.65M
LLY icon
12
Eli Lilly
LLY
$1.07T
$9.13M 0.62%
+55,600
New +$8.53M
NTAP icon
13
NetApp
NTAP
$32.9B
$9.11M 0.62%
+205,243
New +$8.82M
LOGI icon
14
Logitech
LOGI
$15.2B
$9.03M 0.61%
138,177
-18
-0% -$959
TER icon
15
Teradyne
TER
$54.8B
$9.03M 0.61%
106,802
-50,508
-32% -$3.39M
DHI icon
16
D.R. Horton
DHI
$41B
$9M 0.61%
162,315
-12,603
-7% -$611K
FAST icon
17
Fastenal
FAST
$54B
$8.92M 0.61%
416,400
-96,578
-19% -$1.85M
IDXX icon
18
Idexx Laboratories
IDXX
$42.9B
$8.91M 0.61%
+27,000
New +$7.82M
CTAS icon
19
Cintas
CTAS
$82.4B
$8.77M 0.6%
+131,716
New +$7.62M
AMAT icon
20
Applied Materials
AMAT
$426B
$8.69M 0.59%
+143,729
New +$7.75M
PODD icon
21
Insulet
PODD
$11.3B
$8.61M 0.59%
44,306
-11,031
-20% -$2.11M
EA icon
22
Electronic Arts
EA
$52.4B
$8.6M 0.59%
65,110
-21,823
-25% -$2.58M
MKTX icon
23
MarketAxess Holdings
MKTX
$4.15B
$8.57M 0.58%
17,118
+14,488
+551% +$6.75M
LOW icon
24
Lowe's Companies
LOW
$116B
$8.55M 0.58%
63,315
-14,891
-19% -$1.7M
LRCX icon
25
Lam Research
LRCX
$382B
$8.54M 0.58%
264,030
-41,970
-14% -$1.14M

Similar funds

PDT Partners's Q2 2020 Portfolio in Review

As of Q2 2020, PDT Partners held 898 positions worth $1.47B, up 16% from $1.26B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

PDT Partners withdrew a net $137M in Q2 2020, closing 245 positions and reducing 230 holdings. Its most notable exit was AbbVie, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ZENDESK INC worth $10.6M.

  • PDT Partners's largest Q2 2020 buy was ZENDESK INC: 119,997 shares worth $10.6M.
  • PDT Partners added most to Bloom Energy in Q2 2020, an estimated $9.29M increase.
  • PDT Partners's biggest Q2 2020 reduction was EOG Resources, cutting an estimated $17.3M.
  • PDT Partners fully exited AbbVie in Q2 2020, selling an estimated $31.8M.
  • PDT Partners's ten largest holdings make up 9.1% of its $1.47B portfolio in Q2 2020.
  • PDT Partners opened 262 new positions and closed 245 in Q2 2020.
  • PDT Partners's portfolio value rose 16% quarter-over-quarter to $1.47B.

Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.